Table 3. Characteristics of SARI case-patients detected as part of respiratory disease surveillance in the Middle East and Latin America during the COVID-19 pandemic, 2020–2022*.
| Jordan | Latin America | ||
|---|---|---|---|
| Characteristic | No. case-patients (% [95% CI]) | No. case-patients (% [95% CI]) | |
| Total SARI cases |
8,523 |
|
687 |
| Sex | |||
| M | 4,593 (53.9 [52.5–55.3]) | 368 (53.6 [48.5–58.7]) | |
| F |
3,930 (46.1 [44.7–47.6]) |
|
319 (46.4 [41.5–51.8]) |
| Age group | |||
| <16 | 2,931 (34.4 [32.7–36.1]) | 473 (68.9 [64.7–73.0]) | |
| 16–50 | 1,780 (20.9 [19.0–22.8]) | 123 (17.9 [11.1–24.7]) | |
| >50 |
3,812 (44.7 [43.1–46.3]) |
|
91 (13.2 [6.3–20.1]) |
| Positive test result | |||
| Influenza, n = 8,523 | 219 (2.6 [2.3–2.9]) | 52 (7.6 [4.0–14.8]) | |
| SARS-CoV-2, n = 8,144 | 1,361 (16.7 [15.9–17.5]) | 79 (11.5 [4.5–18.5]) | |
| RSV, n = 8,147 | 448 (5.5 [5.0–6.0]) | 134 (19.5 [12.8–26.2]) | |
| Other respiratory pathogens, n = 8,147 | 4,255 (52.2 [51.1–53.3]) | 556 (80.9 [77.6–84.2]) |
*ILI, influenza-like illness; RSV, respiratory syncytial virus; SARI, severe acute respiratory infection.